JORGE M CHAVES
Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology TACOMA, WA NPI 1265610752
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology WA Merck Sharp & Dohme Corporation All categories
General Payments — all program years on this page
$27,371.76
- Category: General Payments
- Program years: PY2018–2024
- Record count: 204
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $979.76 across 48 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $979.76 | 48 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Merck Sharp & Dohme Corporation | $146.42 | 7 |
| ABBVIE INC. | $143.28 | 9 |
| Stemline Therapeutics Inc. | $80.67 | 1 |
| Acerta Pharma LLC | $76.37 | 3 |
| BeiGene USA, Inc. | $66.20 | 3 |
| Regeneron Healthcare Solutions, Inc. | $49.47 | 2 |
| Daiichi Sankyo Inc. | $48.21 | 2 |
| PFIZER INC. | $47.49 | 6 |
| Takeda Pharmaceuticals U.S.A., Inc. | $44.82 | 2 |
| EISAI INC. | $44.36 | 2 |
| Genentech USA, Inc. | $44.32 | 2 |
| Agios Pharmaceuticals, Inc. | $38.71 | 1 |
| Astellas Pharma US Inc | $29.48 | 1 |
| Janssen Biotech, Inc. | $23.11 | 1 |
| Deciphera Pharmaceuticals Inc. | $19.82 | 1 |
| Lilly USA, LLC | $17.87 | 1 |
| TerSera Therapeutics LLC | $17.55 | 1 |
| EMD Serono, Inc. | $14.53 | 1 |
| Genmab U.S., Inc. | $13.56 | 1 |
| Ipsen Biopharmaceuticals, Inc | $13.52 | 1 |
By program year
Records — PY2024 (48)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.